Home2025August13Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease – Novartis Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease – Novartis August 13, 2025betadmin None #stockmarket #breaking
Disney CFO Is Ready to Fight YouTube TV “As Long as They Want To” – The Hollywood Reporter $GOOG Carriage negotiations between the two media giants are ongoing. #stockmarket #breaking
SoftBank Unloads Nvidia Stake for $5.8 Billion in Surprise Move – Yahoo Finance $NVDA The Nvidia stake sale highlights how founder Masayoshi Son needs money to chase a plethora of projects that range from…
Trump eyes privatizing U.S. Postal Service, citing financial losses – The Washington Post $DJT #Trump Trump feuded with the mail agency in his first term. Privatizing it could shake up consumer shipping and business supply chains.…